Many authors have grown synovial cells, both normal and rheumatoid, in culture and studied the Accepted for publication 19 March 1985. Correspondence to Dr Inger Marie S Dahl, Department of Medicine, University Hospital, N-9000 Troms0, Norway. production of hyaluronic acid and the effects of drugs on this activity. However, these studies have been performed mainly with well established cultures when the cells exhibit a fibroblast-like appearance (see e.g., references 3, [6] [7] [8] [9] [10] [11] [12] . It can be argued that the results do not reflect in-vivo hyaluronic acid metabolism. Some studies have, however, been performed on organ cultures where the synovial membrane or villi from this membrane were used. 13 In the present investigation we have attempted to isolate synovial lining cells from normal and rheumatoid joints and to study their hyaluronate production immediately after transfer to culture when they still possess a morphology resembling that shown in vivo. We have found that the normal lining cells under these conditions do not produce any appreciable amount of hyaluronate, whereas the rheumatoid cells produce the polysaccharide but with an unexpectedly low molecular weight. 648 Dahl, Husby 16 The proliferated synovium was carefully dissected under the microscope from fat and fibrous material and cut into small pieces. These were suspended in a balanced salt solution containing 20 mM HEPES pH 7.4, 0-5 g/l of collagenase (Worthington, New Jersey, USA), 0 15 g/l of deoxyribonuclease (Sigma, St Louis, Missouri, USA) and 10 g/l of human serum albumin (AB KABI, Stockholm, Sweden). The mixture was stirred carefully (100 rotations per min) on a New Brunswick incubator shaker for about 2 h at 37°C. Large pieces remaining in the digest were removed by filtration through a sterile Dacron filter (mesh 80). The resulting single cell suspension was cleared from dead cells and subcellular material by centrifugation at room temperature through a cushion of 22% Percoll (Pharmacia Fine Chemicals, Uppsala, Sweden) containing 0-15 g/l of deoxyribonuclease. 16 In three patients the cells were separated according to density on a Percoll gradient. Fractions with densities of 1 043-1-055 g/ml and 1-055-1-080 g/ml were collected. '7 After washing with RPMI medium containing 20% human serum, 50 IU/ml of penicillin, and 50 mg/l of streptomycin the cells were counted in the presence of trypan blue and showed a viability of more than 95%. Only a minor part of the radioactivity incorporated into high molecular weight material was detected in the cellular fraction (20%). The media were made 6-5 M in urea and 0-05 M in trometamol (TRIS)-HCl buffer pH 6-5 and chromatographed on diethylaminoethyl (DEAE)-cellulose as described by Dahl and Coster.24 After application of the samples the columns were eluted stepwise with (a) urea/ TRIS buffer; (b) urea/TRIS+0-15 M NaCl; (c) urealTRIS+0 5 M NaCl; and (d) urea/TRIS+2 M NaCl. The hyaluronate was eluted entirely in the 0-5 M NaCl fraction as shown with high molecular weight standard samples of labelled hyaluronate (kindly supplied by Dr J R E Fraser). The recovery was 70-90%. This fraction was dialysed against distilled water and lyophilised.
CHARACTERISATION OF THE HYALURONATE
The molecular weight distribution of the hyaluronate was determined quantitatively by chromatography on the column of mixed agarose gels described by Laurent and Granath25 or qualitatively by chromatography on Sephacryl S-300 and S-1000 (Pharmacia Fine Chemicals). The chromatographic details are given in the legends to the figures. To confirm the lable was incorporated into hyaluronate, the samples were dissolved in 0-1 M TRIS-HCI buffer pH 7-0 and incubated with hyaluronidase from Streptomyces hyalurolyticus (10 U/ml, 50°C, 12 h, Seikagaku Kogyo, Ltd, Tokyo, Japan) and rechromatographed on Sephacryl columns.
TESTS FOR HYALURONIC ACID DEGRADING ACTIVITY
Experiments were performed to check for possible hyaluronic acid degrading activity in the cultures of rheumatoid cells, in three serum batches used in cell culturing, and finally in serum and synovial fluid from patients with rheumatoid arthritis. Determination in serum was made by incubating 1 The 0-5 M NaCl fraction from DEAE-cellulose, which should contain the hyaluronic acid in the medium, was isolated as described. In order to confirm that the radioactivity of this fraction had been incorporated into hyaluronic acid the material was chromatographed on Sephacryl S-300 or S-1000 before and after treatment with hyaluronidase from Streptomyces hyalurolyticus. The main part of the radioctive material in this fraction produced by rheumatoid cells was susceptible to the enzyme ( Figs  1A and 1B ). There was, however, some material in the void fraction and a distinct peak in the middle of the chromatogram that were unaffected by hyaluronidase. The results in Table 2 concerning the primary cell cultures give both the total incorporation of radioactivity into the 0-5 M NaCl fraction (Fig. 1A) .
Cells dispersed from rheumatoid synovium were incubated for varying times in plastic dishes, and the incorporation of isotope into hyaluronate was measured when the total cell population was present. Non-adherent cells were then removed by washing and the hyaluronate synthesis measured in the adherent cells only (Table 2 ). There was a significant but highly variable hyaluronate production both before and after the non-adherent cells had been removed. The accumulation of hyaluronate in the medium was observed already during the first half hour of culture and continued throughout the period of observation (up to 60 h). There was no apparent difference in the synthesis of hyaluronate in the total cell population compared with the adherent cells.
In two experiments rheumatoid cells were separated by Percoll centrifugation into a high density and a low density fraction.'7 There was no clear difference in hyaluronate production between the two cell populations (data not shown).
The normal synovial lining cells behaved very differently from the rheumatoid cells. Only trace amounts of hyaluronate were produced in the cultures (Fig. IC, Table 2 ). There was, however, an incorporation into the unknown compound, which appears in the middle of the Sephacryl S-300 chromatogram (Fig. IC) .
Fibroblast-like cell lines were established frorm some of the patients and their hyaluronate production was studied after four and seven passages. The production of hyaluronate by these cells is shown in Table 3 . On average these cells seem to synthesise less than the cells in primary cultures (Table 2) , though theTresults are somewhat variable.
The production seems to be independent of the substrate on which the cells grow (plastic, fibronectin, collagen) or the serum added to the medium (human serum, human fetal serum). The aim of the present study was to study the production of hyaluronate in primary cultures of rheumatoid synovial cells, when they still retain the above described morphology, since this, to our knowledge, has not been done before. When cell lines are established from the cultures the cells become fibroblast like, and several authors have shown that at this stage they are producers of hyaluronate.3 612 The synovial and subsynovial layers were carefully dissected from the underlying connective tissue and exposed to collagenase for only a short period to avoid contamination with fibroblasts. In addition, aphidicolin, known to inhibit cell division,18 was added to some of the cultures to prevent multiplication of the fibroblasts. From a morphological standpoint less than 5% of the cells had a fibroblastlike appearance 24 h after the cells had adhered. In addition, more than 90% of the total cell population were esterase positive.
After transfer to in-vitro conditions the rheumatoid synovial cells were shown to produce hyaluronate immediately in amounts equal to or larger than those produced by fibroblast cell lines established from rheumatoid joints (compare Tables 2 and 3) . A pronounced variability in the synthetic rate was observed in cells from different RA patients.
In contrast to the rheumatoid cells, synovial lining cells from normal controls were not found to produce significant amounts of hyaluronate either in cell suspension or when adhered to substrate. The normal cells were obtained by intra-articular administration of trypsin. The use of a different procedure for isolation of the cells was an experimental necessity in work with human material but opens the possibility that different cell populations have been collected from the normal and pathological joints despite a similar morphology when adhered to substrate. It is unlikely that trypsin treatment of the normal cells explains the lack of hyaluronate production, since addition of similar amounts of trypsin did not affect the synthesis in adherent rheumatoid synovial cells. Hyaluronate production has also been shown in numerous cell lines established by the standard method in tissue culture of cells released with trypsin. The appearance of the unknown peak in the middle of the Sephacryl S-300 chromatogram (Fig. 1) shows that normal and rheumatoid cells have additional similarities in their biosynthetic machinery. It could also be argued that the use of collagenase in the dispersion of rheumatoid synovial cells had stimulated synthesis of hyaluronate, though this is unlikely in view of the apparent hyaluronate production in intact organ cultures of rheumatoid synovial tissue. If these objections are borne in mind the most probable explanation of our results is a pronounced increase in hyaluronate synthesis by the synovial cells in rheumatoid arthritis compared with the normal state. The high production could be a source of the increased total amounts of hyaluronate which are found in inflamed joints.
We were suprised by .the observation that the rheumatoid synovial cells and short term organ cultures produced hyaluronate of molecular weight of about 50 000. Vuorio and coworkers'0 31 have previously reported on the synthesis of underdepolymerised hyaluronate by rheumatoid cells as judged chromatographically, but all previous work on the molecular weight of hyaluronic acid in joint fluid has indicated that even if there is a lower degree of polymerisation the molecular weight is still of the order of 106 in rheumatoid joints.32 A recent study on the molecular weight dispersion of hyaluronate from synovial fluid in rheumatoid patients has confirmed that there is no appreciable amount of low molecular weight polymer (Engstrom-Laurent, Dahl, Dahl, and Granath, unpublished). This raises the question whether the low 656 Dahl, Husby molecular weight material is a product of the in vitro conditions.
The hyaluronate in rheumatoid cell cultures could be synthesised in a low molecular weight form but could also be produced by degradation of high molecular weight material. No degradation was detected when hyaluronate was added in trace amounts to the cell or organ cultures from rheumatoid tissue or to serum or joint fluid from rheumatoid patients. This does not exclude the possibility of local degradation at the site of synthesis, e.g., before secretion from the cells. It is known that phagocytic cells produce oxygen-derived free radicals,33 and that these radicals depolymerise hyaluronic acid.34 The radicals have a short lifetime, and their effect should therefore be localised to the neighbourhood of the cell. Free radical formation is therefore a possible explanation for our observation of low molecular hyaluronate. Furthermore, the high oxygen tension in vitro compared with in vivo would promote free radical formation in the cell cultures.
An alternative explanation for the lack of low molecular hyaluronate in synovial fluid could be a rapid disappearance of this material by diffusion through the synovial membranes. It is interesting to note that rheumatoid patients have increased levels of hyaluronate in the general circulation and that this presumably originates from the connective tissues and is due to and it then goes on in quite adequate detail to discuss the materials and the methods used in the most common fracture sites, namely tibia, femur, forearm, and humerus.
Any book on such a subject by two authors will of necessity be slightly idiosyncratic, but this detracts not at all from the efficacy of what they propound.
I find the description of the techniques very clear, and I have no doubt that this book should be to hand for the orthotist or plaster technician involved in day to day fracture bracing.
